Veru is a biopharmaceutical company focused on developing novel medicines for high-quality weight loss, breast cancer, and viral related ARDS.
Company Profile
Industry Classifications
Sector:
Healthcare
Industry:
Biotechnology
NAICS:
Research and Development in Nanotechnology (541713)
SIC:
Pharmaceutical Preparations (2834)
Contact Information
Investor Relations
Samuel Fisch
Executive Director, Investor Relations and Corporate Communications
Veruinvestor@verupharma.com
Company Contact
Veru Inc.
2916 N. Miami Avenue
Suite 1000
Miami, FL 33127
United States
T: 305-509-6897
veruinvestor@verupharma.com